Your browser doesn't support javascript.
loading
An analysis of silybin meglumine tablets in the treatment of drug-induced liver injury as assessed for causality with the updated Roussel Uclaf Causality Assessment Method using a nationwide database.
Zhang, Bo; Jiang, Guosheng; Wang, Li; Li, Xia; Zhao, Chuan; Tan, Qiliang; Kang, Weiwei; Feng, Yuxia; Han, Xian; Raza, Hafiz Khuram; Mao, Yimin.
Afiliación
  • Zhang B; Department of Infectious Diseases, Tai'an Central Hospital, Taian, China.
  • Jiang G; Department of Infectious Diseases, Ningjin County People's Hospital, Ningjin, China.
  • Wang L; Department of Liver Disease, Public Health Clinical Center of Chengdu, Chengdu, China.
  • Li X; Department of Liver Disease, Baoding People's Hospital, Baoding, China.
  • Zhao C; Department of Infectious Diseases, Suining Central Hospital, Suining, China.
  • Tan Q; Department of Liver Disease, Dazhou Central Hospital, Dazhou, China.
  • Kang W; Beijing Youan Hospital, Capital Medical University, Beijing, China.
  • Feng Y; Department of Psychiatry, Luohe Psychiatric Hospital, Luohe, China.
  • Han X; Unimed Scientific Inc., Wuxi, China.
  • Raza HK; Unimed Scientific Inc., Wuxi, China.
  • Mao Y; Division of Gastroenterology and Hepatology, Shanghai Institute of Digestive Disease, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Br J Clin Pharmacol ; 89(4): 1329-1337, 2023 04.
Article en En | MEDLINE | ID: mdl-36278948
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad Hepática Inducida por Sustancias y Drogas / Silibina Tipo de estudio: Clinical_trials / Etiology_studies Límite: Humans Idioma: En Revista: Br J Clin Pharmacol Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad Hepática Inducida por Sustancias y Drogas / Silibina Tipo de estudio: Clinical_trials / Etiology_studies Límite: Humans Idioma: En Revista: Br J Clin Pharmacol Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido